AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34112719 — intervention group
Group type: EXPERIMENTAL
Intervention: GMA (present fidgety movements)
Number of subjects: 50
Study 34626956 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed protein formula (pHF) with synbiotics (scGOS/lcFOS; 9:1) and Bifidobacterium breve M‐16V
Number of subjects: 112
Study 34626956 — intervention group
Group type: COMPARATOR
Intervention: Intact protein infant formula (IF) with scGOS/lcFOS
Number of subjects: 112
Study 34626956 — intervention group
Group type: COMPARATOR
Intervention: Breastfed reference group
Number of subjects: 112
Study 34626956 — intervention group
Group type: COMPARATOR
Intervention: Both formula groups (test and control)
Number of subjects: 112
Study 35617986 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib plus remdesivir plus placebo
Number of subjects: 1010
Study 35617986 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone plus remdesivir plus placebo
Number of subjects: 1010
Study 33674187 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy in 6-IHC score 'High' risk group
Number of subjects: 330
Study 33674187 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy in 6-IHC score 'Low' risk group
Number of subjects: 330
Study 32678376 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted blanket during chemotherapy infusion
Number of subjects: 0
Study 32678376 — intervention group
Group type: COMPARATOR
Intervention: Control group (no weighted blanket during chemotherapy infusion)
Number of subjects: 0
Study 33891981 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-IL-22 (fezakinumab [FZ]) treatment for 12 weeks
Number of subjects: 0
Study 33891981 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 34841959 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-Coke (AS)
Number of subjects: 8
Study 34841959 — intervention group
Group type: EXPERIMENTAL
Intervention: Coca-Cola (NS)
Number of subjects: 8
Study 34841959 — intervention group
Group type: COMPARATOR
Intervention: Water (CON)
Number of subjects: 8
Study 33594802 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MMN) supplementation before 12 gestational weeks
Number of subjects: 18775
Study 33594802 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MMN) supplementation early-onset (<28 weeks)
Number of subjects: 18775
Study 33594802 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MMN) supplementation late-onset (≥28 weeks)
Number of subjects: 18775
Study 33594802 — intervention group
Group type: COMPARATOR
Intervention: Folic acid (FA) supplementation
Number of subjects: 18775
Study 33594802 — intervention group
Group type: COMPARATOR
Intervention: Iron–folic acid (IFA) supplementation
Number of subjects: 18775
Study 32989261 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity shockwave therapy (LiST) - 5000 shockwaves per session with energy flux density 0.1 mJ/mm2, 6 sessions (once/week)
Number of subjects: 45
Study 32989261 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment - 5000 shockwaves from a visually identical sham probe, 6 sessions (once/week)
Number of subjects: 45
Study 36014806 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (200, 800, 1000 mg) during pregnancy
Number of subjects: 1145
Study 33011163 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic elastic intermaxillary fixation (IMF)
Number of subjects: 34
Study 33011163 — intervention group
Group type: COMPARATOR
Intervention: Wire intermaxillary fixation (IMF)
Number of subjects: 34
Study 32480568 — intervention group
Group type: COMPARATOR
Intervention: Fog immersion alone
Number of subjects: 10
Study 32480568 — intervention group
Group type: EXPERIMENTAL
Intervention: Fog drip to the soil and canopy fog immersion
Number of subjects: 10
Study 32480568 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fog water inputs)
Number of subjects: 10
Study 34143979 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab/olaparib/paclitaxel (DOP)
Number of subjects: 372
Study 34143979 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (paclitaxel)
Number of subjects: 372
Study 32329963 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 98
Study 32329963 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 98
Study 32329963 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 98
Study 33188493 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural dexmedetomidine (0.1% ropivacaine with 0.5 µg/mL dexmedetomidine)
Number of subjects: 600
Study 33188493 — intervention group
Group type: COMPARATOR
Intervention: Control group (0.1% ropivacaine alone)
Number of subjects: 600
Study 32369570 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (NSMD with LLLT and NSMD alone)
Number of subjects: 67
Study 35122766 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher induction regimen (adalimumab 160 mg at weeks 0, 1, 2, and 3)
Number of subjects: 514
Study 35122766 — intervention group
Group type: COMPARATOR
Intervention: Standard induction regimen (adalimumab 160 mg at week 0 and 80 mg at week 2)
Number of subjects: 514
Study 35122766 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically adjusted (CA) maintenance therapy
Number of subjects: 514
Study 35122766 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic drug monitoring (TDM) maintenance therapy
Number of subjects: 514
Study 33861434 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin at 250 mg daily for 2 months
Number of subjects: 80
Study 33861434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 34218961 — intervention group
Group type: EXPERIMENTAL
Intervention: ROTAVIN
Number of subjects: 825
Study 34218961 — intervention group
Group type: COMPARATOR
Intervention: ROTAVIN‐M1
Number of subjects: 825
Study 34218961 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ROTAVIN and ROTAVIN‐M1
Number of subjects: 825
Study 32251077 — intervention group
Group type: EXPERIMENTAL
Intervention: Peguero‐Lo Presti criteria
Number of subjects: 240
Study 32251077 — intervention group
Group type: EXPERIMENTAL
Intervention: Cornell criteria
Number of subjects: 240
Study 32251077 — intervention group
Group type: EXPERIMENTAL
Intervention: Sokolow‐‐Lyon voltage criteria
Number of subjects: 240
Study 32251077 — intervention group
Group type: COMPARATOR
Intervention: All criteria
Number of subjects: 240
Study 35367874 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cell (MSC) therapy
Number of subjects: 28
Study 35367874 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study 33762031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D sufficient (25(OH)D ≥ 30 ng/mL)
Number of subjects: 300
Study 33762031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D insufficient (25(OH)D < 30 ng/mL)
Number of subjects: 300
Study 33762031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels above 27.16-30.69 ng/mL
Number of subjects: 300
Study 34860745 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic model incorporating 5 factors (brain lesions on MRI, previous nonspecific neurologic symptoms, low-dose corticosteroids treatment, ocular pain, absence of optic disc/peripapillary hemorrhage)
Number of subjects: 388
Study 34860745 — intervention group
Group type: COMPARATOR
Intervention: Standard practice relying solely on brain lesions on MRI
Number of subjects: 388
Study 33658473 — intervention group
Group type: EXPERIMENTAL
Intervention: 3M respirator
Number of subjects: 41
Study 33658473 — intervention group
Group type: EXPERIMENTAL
Intervention: AoSafety (Medium) respirator
Number of subjects: 41
Study 33658473 — intervention group
Group type: EXPERIMENTAL
Intervention: AoSafety (Large) respirator
Number of subjects: 41
Study 33658473 — intervention group
Group type: EXPERIMENTAL
Intervention: AoSafety (All sizes) respirator
Number of subjects: 41
Study 33658473 — intervention group
Group type: EXPERIMENTAL
Intervention: DUO respirator (one size fits all)
Number of subjects: 41
Study 33658473 — intervention group
Group type: EXPERIMENTAL
Intervention: Climax respirator (one size fits all)
Number of subjects: 41
Study 33658473 — intervention group
Group type: EXPERIMENTAL
Intervention: AoSafety three-size system brands
Number of subjects: 41
Study 35974393 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinyarwanda version of the Diabetes-39 (D-39) questionnaire
Number of subjects: 309
Study 32299284 — intervention group
Group type: EXPERIMENTAL
Intervention: Waived P2Y12 inhibitor copayment costs for 1 year
Number of subjects: 262
Study 32299284 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 262
Study 32299284 — intervention group
Group type: COMPARATOR
Intervention: Pre-study free medication programs
Number of subjects: 262
Study 35894992 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 21
Study 35894992 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and embodiment mechanisms
Number of subjects: 21
Study 33137174 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact precautions added to standard precautions during the intervention period (IP)
Number of subjects: 3283
Study 33137174 — intervention group
Group type: COMPARATOR
Intervention: Standard precautions during the control period (CP)
Number of subjects: 3283
Study 32396866 — intervention group
Group type: EXPERIMENTAL
Intervention: 50th percentile arm
Number of subjects: 4
Study 32396866 — intervention group
Group type: EXPERIMENTAL
Intervention: 75th percentile arm
Number of subjects: 4
Study 32396866 — intervention group
Group type: EXPERIMENTAL
Intervention: 50th percentile with forgiveness arm
Number of subjects: 4
Study 32396866 — intervention group
Group type: EXPERIMENTAL
Intervention: 75th percentile with forgiveness arm
Number of subjects: 4
Study 35462241 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 128
Study 35462241 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior Therapy (BT)
Number of subjects: 128
Study 33926747 — intervention group
Group type: EXPERIMENTAL
Intervention: Online parenting education via WhatsApp
Number of subjects: 32
Study 33926747 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 32
Study 35989585 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (target BrAC = 0.08 g/dl)
Number of subjects: 48
Study 35989585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 33148481 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril and folic acid (10 mg enalapril and 0.8 mg folic acid daily)
Number of subjects: 19644
Study 33148481 — intervention group
Group type: COMPARATOR
Intervention: Enalapril alone (10 mg enalapril daily)
Number of subjects: 19644
Study 33148481 — intervention group
Group type: COMPARATOR
Intervention: Not receiving folic acid (control group for those with elevated serum calcium)
Number of subjects: 19644
Study 32086604 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral approach
Number of subjects: 111
Study 32086604 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsilateral laminotomy
Number of subjects: 111
Study 32086604 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental fusion
Number of subjects: 111
Study 32086604 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial facet cysts
Number of subjects: 111
Study 32086604 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraforaminal facet cysts
Number of subjects: 111
Study 32086604 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediolateral facet cysts
Number of subjects: 111
Study 34992006 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 6
Study 34992006 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg
Number of subjects: 6
Study 34992006 — intervention group
Group type: COMPARATOR
Intervention: TKIs
Number of subjects: 6
Study 34008422 — intervention group
Group type: EXPERIMENTAL
Intervention: Omentum-preserving gastrectomy
Number of subjects: 0
Study 34008422 — intervention group
Group type: COMPARATOR
Intervention: Radical gastrectomy with D2 lymphadenectomy
Number of subjects: 0
Study 35066451 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 68
Study 35066451 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 68
Study 35066451 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 68
Study 33128806 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure (VRE)
Number of subjects: 0
Study 33128806 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy
Number of subjects: 0
Study 33128806 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperarousal symptoms
Number of subjects: 0
Study 33128806 — intervention group
Group type: EXPERIMENTAL
Intervention: Reexperiencing symptoms
Number of subjects: 0
Study 33128806 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance/numbing symptoms
Number of subjects: 0
Study 36216355 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention (M2 group)
Number of subjects: 89
Study 36216355 — intervention group
Group type: COMPARATOR
Intervention: Routine preoperative health education (M1 group)
Number of subjects: 89
Study 33915104 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV‐10
Number of subjects: 347
Study 33915104 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV‐23
Number of subjects: 347
Study 33915104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 347
Study 34719137 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative Care Always: Hepatology (PCA:Hep) online course
Number of subjects: 39
Study 32389220 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic testing
Number of subjects: 0
Study 32389220 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveys and telephone check-ins
Number of subjects: 0
Study 35940597 — intervention group
Group type: EXPERIMENTAL
Intervention: Coleadership model
Number of subjects: 0
Study 35940597 — intervention group
Group type: COMPARATOR
Intervention: Singular leadership model
Number of subjects: 0
Study 33538534 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone maintenance treatment (4-8 mg/d)
Number of subjects: 161
Study 36494619 — intervention group
Group type: EXPERIMENTAL
Intervention: MSnetWork intervention (multidisciplinary care network)
Number of subjects: 950
Study 33655906 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone (SP) group (Relaxation by smartphones)
Number of subjects: 360
Study 33655906 — intervention group
Group type: COMPARATOR
Intervention: Control group (No relaxation)
Number of subjects: 360
Study 32244252 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab-CyBorD
Number of subjects: 28
Study 33852498 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose epidural fentanyl (≥100 μg)
Number of subjects: 80
Study 33852498 — intervention group
Group type: COMPARATOR
Intervention: Low-dose epidural fentanyl (<100 μg)
Number of subjects: 80
Study 32146300 — intervention group
Group type: EXPERIMENTAL
Intervention: cRCTs implementation
Number of subjects: 22
Study 32146300 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to trial conduct
Number of subjects: 22
Study 32146300 — intervention group
Group type: EXPERIMENTAL
Intervention: Research agenda
Number of subjects: 22
Study 32997098 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose rivaroxaban and aspirin
Number of subjects: 4129
Study 32997098 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 4129
Study 32013285 — intervention group
Group type: EXPERIMENTAL
Intervention: Paresthesia-based tonic stimulation
Number of subjects: 174
Study 32013285 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical history
Number of subjects: 174
Study 32013285 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 174
Study 32013285 — intervention group
Group type: COMPARATOR
Intervention: Control group (failed SCS trials)
Number of subjects: 174
Study 32013285 — intervention group
Group type: COMPARATOR
Intervention: Number of leads, pain duration, characteristics, and category (nociceptive vs neuropathic)
Number of subjects: 174
Study 32013285 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between surgical spine history and lower extremity pain
Number of subjects: 174
Study 35753877 — intervention group
Group type: EXPERIMENTAL
Intervention: Authentic cervical manipulation
Number of subjects: 31
Study 35753877 — intervention group
Group type: COMPARATOR
Intervention: Sham cervical manipulation
Number of subjects: 31
Study 34341406 — intervention group
Group type: EXPERIMENTAL
Intervention: Galvanization and potassium iodide iontophoresis
Number of subjects: 50
Study 34341406 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study 32740180 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing
Number of subjects: 71
Study 32740180 — intervention group
Group type: COMPARATOR
Intervention: Current care procedure (without hydrocolloid dressing)
Number of subjects: 71
Study 33662659 — intervention group
Group type: EXPERIMENTAL
Intervention: 9,000 IU/kg vitamin A
Number of subjects: 360
Study 33662659 — intervention group
Group type: COMPARATOR
Intervention: VA supplementation groups
Number of subjects: 360
Study 33662659 — intervention group
Group type: EXPERIMENTAL
Intervention: 6,000, 9,000, and 12,000 IU/kg vitamin A
Number of subjects: 360
Study 36308037 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized skin care regimen including once daily leave-on product application (lipid content 21%)
Number of subjects: 160
Study 36308037 — intervention group
Group type: COMPARATOR
Intervention: Skin care as preferred by the parents (Control)
Number of subjects: 160
Study 33545956 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipi Guben decoction (LPGBD)
Number of subjects: 100
Study 34882826 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 40
Study 34882826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33319947 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Needle Tip Positioning (DNTP)
Number of subjects: 142
Study 33319947 — intervention group
Group type: COMPARATOR
Intervention: Conventional Long-Axis In-Plane (LAX-IP)
Number of subjects: 142
Study 32684367 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of GWAS results with gene expression and DNA methylation levels.
Number of subjects: 0
Study 32684367 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of expression and methylation quantitative trait loci datasets of adult brain and blood.
Number of subjects: 0
Study 33847575 — intervention group
Group type: COMPARATOR
Intervention: IPACK block
Number of subjects: 60
Study 33847575 — intervention group
Group type: EXPERIMENTAL
Intervention: Genicular nerve block
Number of subjects: 60
Study 33847575 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 35294546 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 419
Study 35294546 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 419
Study 32394657 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming acupuncture, 50 min each treatment, once daily, at the interval of 1 day after 4-day treatment, until ovulatory stage.
Number of subjects: 72
Study 32394657 — intervention group
Group type: COMPARATOR
Intervention: Control group received nuangong yunzi capsules, 3 capsules each time, three times a day, until ovulatory stage.
Number of subjects: 72
Study 36083983 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor residual spraying (ORS) with a capsule suspension of lambda-cyhalothrin for two days in October.
Number of subjects: 12
Study 36083983 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 12
Study 33871631 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention decision aid (evidence-based information on overdetection, breast cancer mortality reduction, and false-positives)
Number of subjects: 879
Study 33871631 — intervention group
Group type: COMPARATOR
Intervention: Control decision aid (identical but without overdetection information)
Number of subjects: 879
Study 33871631 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 879
Study 33871631 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 879
Study 34626144 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 251
Study 34626144 — intervention group
Group type: EXPERIMENTAL
Intervention: Blonanserin
Number of subjects: 251
Study 34626144 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone
Number of subjects: 251
Study 33413494 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR tools designed using behavioral principles (salience, choice architecture, defaulting)
Number of subjects: 81
Study 33413494 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 81
Study 33413494 — intervention group
Group type: EXPERIMENTAL
Intervention: Up to 5 most promising stage 1 interventions
Number of subjects: 81
Study 33413494 — intervention group
Group type: COMPARATOR
Intervention: Usual care (for stage 1 providers in unselected arms)
Number of subjects: 81
Study 33413494 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantities of medication prescribed and utilized
Number of subjects: 81
Study 33413494 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically significant adverse outcomes
Number of subjects: 81
Study 34887183 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural block (CEB) using 0.5 mg/kg of 0.125% bupivacaine (Marcaine)
Number of subjects: 60
Study 34157865 — intervention group
Group type: EXPERIMENTAL
Intervention: TICI 3
Number of subjects: 141
Study 34157865 — intervention group
Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 141
Study 34196240 — intervention group
Group type: EXPERIMENTAL
Intervention: Face mask trials
Number of subjects: 12
Study 34196240 — intervention group
Group type: COMPARATOR
Intervention: Control trials (no mask)
Number of subjects: 12
Study 33295955 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 240
Study 33295955 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 240